Gabriella M. Ferrandina
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 282 publications
A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies.
Journal: Gynecologic oncology
Published: March 23, 2026
Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 11, 2026
Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot Multicenter Italian Trials in Ovarian Cancer (MITO) study.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: June 30, 2025
An exploratory assessment of early and delta PET radiomic features for outcome prediction in locally advanced cervical cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 13, 2025
Factors associated with bilateral sentinel lymph node mapping failure using indocyanine green in patients with apparent early-stage cervical cancer: An Italian retrospective multi-center study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 20, 2025
Treatment of Oligometastatic Parenchymal Lesions in Ovarian Cancer With Stereotactic Ablative Radiation Therapy: A Multicenter Prospective Phase 2 Trial (MITO RT3/RAD).
Journal: International journal of radiation oncology, biology, physics
Published: January 14, 2025
Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 13, 2025
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups.
Journal: Anti-cancer drugs
Published: January 09, 2025
In Reply to Gurlek et al.
Journal: International journal of radiation oncology, biology, physics
Published: December 23, 2024
Author Correction: The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
Journal: Cell death & disease
Published: October 21, 2024
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial.
Journal: International journal of radiation oncology, biology, physics
Published: July 05, 2024
Last Updated: 09/26/2026